The gap junction modifier, GAP-134 [(2S,4R)-1-(2-aminoacetyl)-4-benzamido-pyrrolidine-2-carboxylic acid], improves conduction and reduces atrial fibrillation/flutter in the canine sterile pericarditis model.
| Image |  |
|---|---|
| Description | scientific article published on 27 February 2009 |
| Author/s |
author: Stephen J Gardell Ketil Haugan |
| Publication date | February 27, 2009 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |